Fundraising FoxAvammune
5 known investors
Find your way into Avammune
Avammune is a biotech company developing novel therapeutic modalities to address hard-to-treat cancers with distinct mechanisms of action. The company focuses on patient-centric oncology drug discovery, emphasizing improved compliance, ease of administration, and greater accessibility.
Founders & leadership
A
ArunFounder | CEO
A
AdityaFounder | CSO
S
SrinivasanFounder | Director
Investors · 5
1Crowdlisted by 1Crowd
How we know: funding news · press coverage · Not right? Tell us
Shastra VClisted by Shastra VC$550K – $12M
How we know: Shastra VC's portfolio page · funding news · press coverage · Not right? Tell us
IvyCap VenturesreportedMumbai · $300K – $33M
How we know: funding news · press coverage · Not right? Tell us
The Chennai AngelsreportedChennai · $148K – $1.5M
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Avammune do?
- Avammune is a biotech company developing novel therapeutic modalities to address hard-to-treat cancers with distinct mechanisms of action. The company focuses on patient-centric oncology drug discovery, emphasizing improved compliance, ease of administration, and greater accessibility.
- Who founded Avammune?
- Avammune was founded by Arun, Aditya, Srinivasan.
- Who are Avammune's investors?
- Avammune's investors include 1Crowd, Capital2B, Shastra VC, IvyCap Ventures, The Chennai Angels.